RECIST news and updates
21 May 2015
Hear Lesley Seymour and Jan Bogaerts discuss with Helen Saul of EJC News the challenges and possibilities for RECIST
The RECIST Working Group was established in 1995 to review the objective response criteria in use at the time and to explore the utility of the use of unidimensional measurements in response assessment, as proposed by NCIC CTG. The initial working group was led by academic members of the EORTC, NCIC CTG and NCI (USA), with a database being created and maintained under the governance of the EORTC. Over the years, the membership of the Working Group was expanded to include other interested or expert members, including some representation from the pharmaceutical industry, as original members joined pharma, or expertise was identified. RECIST v1 was successfully implemented in 2000, and an update (RECIST 1.1) was released in 2009.
At the TAT Congress held in Paris on 2-4 March 2015, Lesley Seymour (NCIC Clinical Trials Group, Canada and co-chair of the RECIST Working Group) and Jan Bogaerts (Methodology Director EORTC Headquarters in Brussels) respectively chaired and spoke at a ‘Beyond RECIST’ session.
Related News
EORTC participation at ISPOR Europe 2025 conference
7 Nov 2025
EORTC Quality of Life Group participating at the ISOQOL 2025 Conference
22 Oct 2025
New results and forthcoming trials presented at ESMO 2025 underline EORTC’s commitment to patient-centred research
21 Oct 2025
EORTC celebrates the 100th anniversary of p-value on World Statistics Day
20 Oct 2025
EORTC Announces Final Overall Survival Results from the PEACE-3 Trial
19 Oct 2025
Results from EORTC trial define new standard of care for aggressive brain tumours
18 Oct 2025
EORTC’s presence at ESMO 2025
17 Oct 2025
EORTC’s presence at EANO 2025
16 Oct 2025
EORTC celebrates Pink October: shaping the future of breast cancer care
15 Oct 2025
EORTC shines a light on advancements in radioligand therapy
8 Oct 2025
